Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study.

Durand CP, Eatherly M, Yao A, Dollear TJ, Inneh A, Patel U

Open source

DOI
10.1111/dom.70923
Published
2026 Sep
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.70923,
  title = {Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study.},
  author = {Durand CP and Eatherly M and Yao A and Dollear TJ and Inneh A and Patel U},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70923},
  url = {https://doi.org/10.1111/dom.70923}
}

RIS

TY  - JOUR
TI  - Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study.
AU  - Durand CP
AU  - Eatherly M
AU  - Yao A
AU  - Dollear TJ
AU  - Inneh A
AU  - Patel U
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70923
UR  - https://doi.org/10.1111/dom.70923
ER  - 

APA

CP, D., M, E., A, Y., TJ, D., A, I., & U, P. (2026). Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70923

Source records